Exploration of calcium and amino acids for children with primary cardiomyopathies based on genetic characteristics
These videos have been matched automatically. Contact us if they are not relevant.
These videos have been matched automatically. Contact us if they are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.Electrolytes like calcium and amino acids (AAs) show promise in treating pediatric cardiomyopathies (PCMs). Calcium supplements improved heart function in children with dilated cardiomyopathy (DCM), suggesting potential therapeutic roles.
Area Of Science
- Cardiology
- Genetics
- Pediatrics
Background
- Pediatric primary cardiomyopathies (PCMs) are rare, complex genetic disorders with limited treatment options.
- The role of electrolytes and amino acids (AAs) in PCMs remains understudied.
- This research investigates clinical features and nutrient influences in pediatric cardiomyopathy patients.
Purpose Of The Study
- To explore clinical characteristics of pediatric primary cardiomyopathies (PCMs).
- To investigate the association between electrolytes, amino acids (AAs), and genetic mutations in PCMs.
- To evaluate the therapeutic potential of calcium and AAs in pediatric cardiomyopathy.
Main Methods
- Genetic analysis of 27 children with PCMs.
- Identification of common mutated genes in dilated cardiomyopathy (DCM) and hypertrophic cardiomyopathy (HCM).
- Assessment of calcium's effect on heart function in DCM patients.
Main Results
- Identified prevalent mutated genes in DCM (e.g., TTN, MYH7) and HCM (e.g., MYBPC3, MYH7).
- Linked specific electrolytes and AAs (serine, cysteine, arginine) to identified gene mutations.
- Observed significant heart function improvement in 17 children treated with calcium.
Conclusions
- Calcium supplementation may benefit children with dilated cardiomyopathy (DCM).
- Amino acids (serine, cysteine, arginine) show potential as adjunctive therapies for both DCM and HCM.
- Further research into nutrient-based therapies for pediatric cardiomyopathies is warranted.
These videos have been matched automatically. Contact us if they are not relevant.
These videos have been matched automatically. Contact us if they are not relevant.
Related Concept Videos
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...